Literature DB >> 7377158

Acute caffeine overdose in the neonate.

W Banner, P A Czajka.   

Abstract

To our knowledge, the clinical course of acute caffeine poisoning in neonates has not been previously reported. Three full-term infants manifested CNS irritability after the parenteral administration of large doses of caffeine and benzoate sodium injection in the delivery room for respiratory depression. The infants received caffeine in doses that ranged from 36 to 136 mg/kg. On arrival in a regional newborn center, they exhibited one or more of the following symptoms: tachypnea, fine tremor of the extremities, opisthotonus, tonic-clonic movements, and nonpurposeful jaw and lip movements. The overdose of caffeine produced a clinical picture that suggested neonatal seizures and prompted therapy with anticonvulsants. A fourth infant (premature) attained a high plasma caffeine concentration, but this infant's symptoms were altered by intraventricular hemorrhage. The combination of caffeine overdose and perinatal asphyxia may precipitate or increase seizure activity in the neonate. Recognition of the potential toxic effects of caffeine overdose should guide patient care and stimulate further study to establish appropriate use of caffeine in the newborn infant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377158     DOI: 10.1001/archpedi.1980.02130170045015

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Acute caffeine poisoning in a child.

Authors:  P G Jorens; J M Van Hauwaert; M I Selala; P J Schepens
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

3.  Clinical toxicology in the neonatal intensive care unit.

Authors:  W Banner
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 4.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 5.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

Review 6.  Risks and benefits of therapies for apnoea in premature infants.

Authors:  J M Hascoet; I Hamon; M J Boutroy
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 7.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Pharmacokinetic aspects of caffeine in premature infants with apnoea.

Authors:  R Gorodischer; M Karplus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Early High-Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study.

Authors:  Zachary A Vesoulis; Christopher McPherson; Jeffrey J Neil; Amit M Mathur; Terrie E Inder
Journal:  J Caffeine Res       Date:  2016-09-01

Review 10.  Caffeine citrate: a review of its use in apnoea of prematurity.

Authors:  A M Comer; C M Perry; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.